CFH rs1061170: Understanding the Y402H Variant and Eye Health
The rs1061170 variant, frequently referred to as Y402H, is a common genetic change located within the CFH gene. It is widely studied for its association with an increased susceptibility to age-related macular degeneration (AMD) due to its role in regulating the body's immune complement pathway.
What each genotype means
Typical risk baseline
You carry two copies of the common G allele at rs778293. In published studies, this baseline non-risk genotype is not associated with increased susceptibility to age-related macular degeneration. Because evidence for rs778293 itself is limited, overall eye health is primarily influenced by broader CFH risk haplotypes, lifestyle factors like smoking, and age.
Carried by approximately 30% to 45% of individuals of European ancestry, and significantly more prevalent in East Asian populations where the minor allele is rarer.
Modestly increased risk marker
You carry one copy of the A allele at rs778293. This non-coding variant has shown limited direct evidence of risk but exists in moderate to high linkage disequilibrium with primary CFH risk haplotypes linked to age-related macular degeneration in European cohorts. Having one copy confers a modest statistical correlation with risk in population studies, though it is not diagnostic of eye disease.
Observed in roughly 45% to 50% of individuals of European ancestry, with lower frequencies documented in African and East Asian populations.
Elevated risk marker
You carry two copies of the minor A allele at rs778293. This genotype is statistically tagged to CFH haplotype blocks associated with complement pathway activation and increased risk for age-related macular degeneration in European populations. However, evidence directly implicating rs778293 remains limited, and most individuals with this marker do not develop severe visual loss.
Present in approximately 12% to 20% of people of European descent; it occurs at substantially lower rates across Asian and African populations.
What is the rs1061170 Variant?
The rs1061170 variant is a single-nucleotide polymorphism (SNP) found in the CFH gene, which is located on chromosome 1. In scientific literature, this specific variant is often called Y402H because it results in a substitution of the amino acid histidine for tyrosine at position 402 of the complement factor H protein. This change occurs in a region of the protein responsible for binding to heparin and C-reactive protein, which are critical components of the body's inflammatory response. Because this variant is common in many populations, it has been the subject of extensive research to determine how it influences the function of the complement system, a part of the immune system that helps clear pathogens and cellular debris. Understanding this SNP requires looking at how this structural change in the protein might alter its ability to protect tissues from unintended immune system activation.
The Role of the CFH Gene
The CFH gene provides instructions for making complement factor H, a protein that acts as a vital regulator of the alternative complement pathway. This pathway is a component of the innate immune system that, when activated, helps the body fight infections and remove damaged cells. However, this system must be tightly controlled to prevent it from attacking the body's own healthy tissues. Complement factor H functions as an inhibitor, preventing the complement system from becoming overactive. By acting as a cofactor for complement factor I, it helps break down C3b, a molecule that triggers the complement cascade. When the CFH gene carries the Y402H variant, the resulting protein may have impaired functionality, potentially leading to chronic, low-level inflammation in the eye. This persistent inflammatory environment is thought to contribute to the development of age-related macular degeneration (AMD) over time.
Research and Evidence Strength
The association between the rs1061170 (Y402H) variant and age-related macular degeneration is well-documented in scientific literature, particularly in European populations. Numerous studies, including large-scale meta-analyses, have identified this variant as a significant genetic risk factor, with the C allele often associated with a higher risk of developing AMD compared to the T allele. While the evidence for this association is strong, it is important to note that AMD is a complex, multifactorial condition. Genetics is only one piece of the puzzle; environmental factors such as smoking, diet, and age also play substantial roles in disease progression. Furthermore, the impact of this variant can vary significantly across different ancestral backgrounds. While it is a major risk factor in many Caucasian populations, its frequency and clinical impact in other global populations are different, highlighting the need for caution when generalizing these findings.
Population Frequency
The frequency of the rs1061170 variant varies significantly across different global populations. Research indicates that the variant is relatively common in European populations, where the risk-associated allele is frequently observed. In contrast, studies have shown lower frequencies in East Asian populations. Because the prevalence of the variant differs by ancestry, the genetic risk profile for AMD is not uniform worldwide. Researchers continue to study these frequency differences to better understand the evolutionary history of the variant and its specific impact on health outcomes in diverse groups.
Managing Genetic Information
Learning about your genotype for rs1061170 can provide insight into your genetic predisposition, but it is not a diagnostic tool for age-related macular degeneration. Having a higher-risk genotype does not mean an individual will definitely develop the condition, nor does having a lower-risk genotype guarantee protection. Because AMD is influenced by a combination of genetic, environmental, and lifestyle factors, this information should be viewed as one small part of your overall health profile. If you are concerned about your eye health or have a family history of macular degeneration, the most effective step is to consult with an eye care professional, such as an ophthalmologist or optometrist. They can provide comprehensive screenings and personalized advice based on your clinical history. Always discuss any health concerns or potential lifestyle changes with a qualified healthcare provider rather than relying solely on genetic data.
How common is this variant?
The rs1061170 variant is common in European populations, with frequencies ranging significantly when compared to East Asian or other global groups.
Frequently asked questions
Is rs1061170 a diagnostic test for AMD?
No, rs1061170 is not a diagnostic test. It is a genetic marker associated with an increased risk of developing age-related macular degeneration, but it cannot predict whether an individual will develop the disease.
Can I change my risk associated with the CFH variant?
While you cannot change your genetics, you can manage modifiable risk factors for AMD. Maintaining a healthy diet, avoiding smoking, and getting regular eye exams are recommended strategies for supporting long-term eye health.
Does this variant affect how I respond to eye medication?
Some research has investigated whether CFH variants influence the response to anti-VEGF treatments for AMD, but results are mixed. Always discuss any concerns regarding medication efficacy or dosing with your ophthalmologist.
Why is this variant called Y402H?
The name Y402H refers to the specific amino acid change caused by the variant. It indicates that at position 402 of the protein, the amino acid tyrosine (Y) is replaced by histidine (H).
Sources & further reading
Educational information only, last refreshed 10/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs778293?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CFH
This regulatory variant in the CFH locus is linked to complement system dysregulation and is a recognized genetic risk factor for age-related macular degeneration.
Intronic single nucleotide variant in the CFH region associated with susceptibility to age-related macular degeneration (AMD).
Common variant in the CFH locus strongly associated with risk of age-related macular degeneration (AMD).
Intronic marker in CFH forming critical susceptibility haplotypes for choroidal neovascularization and macular atrophy.
Intergenic/intronic variant within the CFH cluster contributing to phenotypic variation in retinal complement activation.
Genomic marker in CFH frequently co-inherited in haplotypes modulating risk of late-stage visual loss from macular degeneration.